Clinical Research
Off-shoring: A Country Attractiveness Index for Clinical Trials
By Mark P. Mathieu
For many years, pharmaceutical companies have been off-shoring manufacturing operations to lower-cost countries. Healthy margins and strong risk aversion have afforded pharmaceutical companies the luxury of staying close to home, for all but manufacturing activities. As financial pressures increase, pharmaceutical executives are finding that going offshore is not only less risky than it once was, but also too attractive to ignore. Read More
|
|
|
Early Trial Planning Solutions
Jun 21 | eCliniqua | Medidata announced two new products at the Drug Information Association (DIA) meeting this week in Washington, D.C.: an updated version of Grants Manager and Medidata Balance.
|
|
Ludwig Institute Chooses Medidata EDC
May 19 | News Brief | Ludwig Institute for Cancer Research has chosen Medidata Rave as its electronic data capture and clinical data management solution.
|
|
Integrating InForm EDC at Dana-Farber Cancer Institute
May 3 | eCliniqua | The Dana-Farber/Harvard Cancer Center, the largest cancer center in the United States, runs about 800 cancer clinical trials per year. And yet until 2000, all of those trials were tracked on paper, and researchers were still grappling with data gaps common to paper records.
|
|
More than Data Integration: A Vision for “eClinical”
Mar 15 | Expert Commentary | The aim of integration of technologies is certainly the sharing of common datato ensure that all systems have the most up to date information, data don’t need to be re-keyed, and discrepancies are reconciled between applications.
|
|
Implementing Core Clinical Trial Technologies
Feb 16 | Expert Commentary | In the clinical space today, more technology solutions are being used, and investigational sites often employ multiple solutions within a single study to perform their responsibilities. Solutions include clinical trials management systems, electronic data capture systems, electronic patient reported outcomes solutions, randomization and trial supply management solutions (typically deployed using IVR/IWR technology), medical imaging technologies, central ECG management and reporting solutions, adverse event and safety systems to name but a few.
|
|
OmniComm Links EDC to HealthVault
Jan 27 | RFP Connect | OmniComm Systems has announced its TrialMaster EDC is now connected to Microsoft HealthVault.
|
|
OmniComm Strives to be a Tier I eClinical Player
Oct 20 | OmniComm Systems is on a roll. In a few short years, it has essentially come from nowhere and is now positioned as the Number 3 electronic data capture (EDC) player.
|
|
In Conversation: Oracle’s Patti Gaves on EDC and Integration
Oct 13 | In a recent conversation with industry veteran Patti Gaves of Oracle Health Sciences Global Business Unit, eCliniqua was curious about her perspective on the current status of electronic data capture (EDC), the industry’s strong focus on integration of electronic point solutions, and the evolution toward eClinical trials.
|
|
Microsoft in Life Science Arena
Oct 5 | A few short months after naming Merck & Co. as a customer and development partner, Microsoft has attracted a sizable following to its life sciences platform intent on helping scientists design better drugs, sponsors better interpret clinical trial results, and physicians better match treatments to patients.
|
|
Infinity’s EDC Evolution
July 7, 2009 | Last April Infinity Pharmaceuticals hit a major bump in the road when a review of the first few dozen patients in its Phase III trial for its lead compound prompted the company to instantly halt the trial. But Infinity still seems to be on the right track.
|
 Meeting Today’s Challenges in Clinical Trial Supply Management
Sponsored by: Medidata Solutions Worldwide
Setting up and managing the clinical trial involves many complex procedures. Among the most challenging are planning and executing the logistics of the trial’s clinical supplies. This podcast focuses in depth on the following topics which trace current practices and future evolution of this crucial aspect of clinical trials:
- Current practices in clinical trial logistics
- Comparing advances in clinical supply practices to other aspects of clinical trials
- Where current practices fall short of meeting the challenges
- Trends and evolving improvements that may change the way logistics are conducted
Listen Now
More Podcasts
Scientific Software Engineer
Boston MA
$70,000 to $95,000
Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET.
Apply at http://jobs.tessella.com
Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes. As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers. This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions. It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply
Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules. It is therefore suitable for use in a variety of markets including scientific research and clinical applications. As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team. The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market. This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company. Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial leadership, who wish to apply a fresh approach to existing markets. Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries. We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products. Click to Apply
|
|
|